Press-release for stocks related to results for sanofi

tags : Results entities : Sanofi

save search

CureVac Announces Financial Results for the Fourth Quarter and Full-Year 2023 and Provides Business Update
Published: 2024-04-24 (Crawled : 13:00) - biospace.com/
SNY | News | $46.66 -2.16% -2.21% 1.7M

Health Technology

| 0.0% | O: 0.82% H: 0.0% C: 0.0%
CVAC | $2.51 -3.46% -3.59% 1.1M

Health Technology

| 0.0% | O: -5.77% H: 0.0% C: 0.0%
BNTX | News | $88.18 -0.35% -0.35% 280K

Health Technology

| 0.0% | O: 0.24% H: 0.0% C: 0.0%
business update for financial results

Nurix Therapeutics Reports First Quarter Fiscal 2024 Financial Results and Provides a Corporate Update
Published: 2024-04-10 (Crawled : 11:00) - globenewswire.com
SNYNF | News | $94.25 -2.18% 480

Health Technology

| -0.01% | O: -0.01% H: 0.0% C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M

Health Technology

| -0.99% | O: -0.32% H: 0.0% C: 0.0%
NRIX | $13.73 -2.83% -2.91% 520K

Health Technology

| 0.32% | O: 18.35% H: 1.98% C: -5.88%
first update therapeutics financial results

Adagene Reports Full Year 2023 Financial Results and Provides Corporate Update
Published: 2024-03-29 (Crawled : 13:00) - globenewswire.com
SNYNF | News | $94.25 -2.18% 480

Health Technology

| Email alert Add to watchlist
ADAG | $2.65 -2.63% 740

Manufacturing

| Email alert Add to watchlist
SNY | News | $46.66 -2.16% -2.21% 1.7M

Health Technology

| Email alert Add to watchlist
year update financial results

DarioHealth Reports Fourth Quarter and Full-Year 2023 Financial and Operating Results
Published: 2024-03-28 (Crawled : 12:00) - biospace.com/
SNYNF | News | $94.25 -2.18% 480

Health Technology

| -5.47% | O: -1.17% H: 0.0% C: -0.89%
SNY | News | $46.66 -2.16% -2.21% 1.7M

Health Technology

| -5.35% | O: -0.96% H: 0.0% C: 0.0%
DRIO | $1.51 4.14% 3.97% 40K

Health Technology

| -4.61% | O: -4.61% H: 14.48% C: 5.52%
financial results

Innate Pharma Reports Full Year 2023 Financial Results and Business Update
Published: 2024-03-21 (Crawled : 09:00) - biospace.com/
SNYNF | News | $94.25 -2.18% 480

Health Technology

| -0.65% | O: 0.14% H: 0.24% C: 0.24%
SNY | News | $46.66 -2.16% -2.21% 1.7M

Health Technology

| -0.55% | O: 0.3% H: 0.0% C: 0.0%
IPHA | $2.47 4.22% 4.05% 690

Health Technology

| -5.2% | O: -4.51% H: 4.25% C: 0.96%
pharma business year update financial results

Innovent Announces 2023 Annual Results and Business Updates
Published: 2024-03-20 (Crawled : 12:30) - biospace.com/
SNYNF | News | $94.25 -2.18% 480

Health Technology

| -0.66% | O: -0.01% H: 0.0% C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M

Health Technology

| -0.52% | O: 0.03% H: 0.0% C: 0.0%
business results

CytoSorbents Reports Fourth Quarter and Full Year 2023 Results
Published: 2024-03-14 (Crawled : 21:00) - globenewswire.com
SNY | News | $46.66 -2.16% -2.21% 1.7M

Health Technology

| -2.83% | O: -0.02% H: 0.0% C: 0.0%
CTSO | $0.821 -6.6% -7.06% 180K

Health Technology

| -9.27% | O: -1.02% H: 0.0% C: -8.33%
year results

Innate Pharma Announces Conference Call and Webcast for Full Year 2023 Financial Results
Published: 2024-03-14 (Crawled : 09:00) - biospace.com/
SNY | News | $46.66 -2.16% -2.21% 1.7M

Health Technology

| -2.61% | O: 0.23% H: 0.0% C: 0.0%
IPHA | $2.47 4.22% 4.05% 690

Health Technology

| -5.2% | O: -2.4% H: 3.69% C: 3.28%
pharma conference year financial results

Sangamo Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2023 Financial Results
Published: 2024-03-13 (Crawled : 13:00) - biospace.com/
SNY | News | $46.66 -2.16% -2.21% 1.7M

Health Technology

| -2.65% | O: -0.04% H: 0.0% C: 0.0%
SGMO | News | $0.4911 -5.72% -6.07% 1.2M

Health Technology

| -39.61% | O: 2.19% H: 4.55% C: -10.78%
business year therapeutics financial results

Press Release: New Phase 2b results for amlitelimab support potential for best-in-class maintenance of response in atopic dermatitis
Published: 2024-03-11 (Crawled : 06:00) - globenewswire.com
SNY | News | $46.66 -2.16% -2.21% 1.7M

Health Technology

| -2.08% | O: 0.57% H: 0.0% C: 0.0%
dermatitis response potential results

MacroGenics Provides Update on Corporate Progress and 2023 Financial Results
Published: 2024-03-07 (Crawled : 21:00) - globenewswire.com
SNY | News | $46.66 -2.16% -2.21% 1.7M

Health Technology

| -2.16% | O: -0.08% H: 0.0% C: 0.0%
MGNX | $15.7 -3.27% -3.38% 520K

Health Technology

| -20.87% | O: -5.7% H: 11.12% C: -9.88%
update financial results

IGM Biosciences Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
Published: 2024-03-07 (Crawled : 21:00) - globenewswire.com
SNY | News | $46.66 -2.16% -2.21% 1.7M

Health Technology

| -2.16% | O: -0.08% H: 0.0% C: 0.0%
IGMS | $7.95 3.25% 3.14% 690K

Health Technology

| -36.52% | O: 2.14% H: 9.69% C: 0.97%
year update financial results

Innovent released the results of two clinical studies of IBI311 (an anti-IGF-1R monoclonal antibody) in oral presentations at the Asia-Pacific Academy of Ophthalmology Congress and International Congress of Endocrinology 2024
Published: 2024-03-07 (Crawled : 04:00) - prnewswire.com
SNY | News | $46.66 -2.16% -2.21% 1.7M

Health Technology

| -0.58% | O: 1.62% H: 0.0% C: 0.0%
ibi311 congress international results

Alnylam Reports Positive KARDIA-2 Topline Study Results Demonstrating Clinically Significant Blood Pressure Reductions When Zilebesiran is Added to Standard of Care Antihypertensives
Published: 2024-03-05 (Crawled : 16:00) - biospace.com/
SNY | News | $46.66 -2.16% -2.21% 1.7M

Health Technology

| 0.13% | O: 1.17% H: 0.0% C: 0.0%
ALNY | $143.8 -1.55% -1.58% 390K

Health Technology

| -2.65% | O: -0.73% H: 1.52% C: 0.5%
positive blood care topline results study

Inhibrx Reports Fourth Quarter and Fiscal Year 2023 Financial Results
Published: 2024-02-28 (Crawled : 19:00) - biospace.com/
SNY | News | $46.66 -2.16% -2.21% 1.7M

Health Technology

| -2.67% | O: -0.63% H: 0.0% C: 0.0%
INBX | $34.385 0.75% 0.74% 210K

Health Technology

| -13.73% | O: -0.86% H: 0.13% C: -5.66%
year financial results

Full-year 2023 results
Published: 2024-02-28 (Crawled : 18:00) - globenewswire.com
SNYNF | News | $94.25 -2.18% 480

Health Technology

| -2.28% | O: -1.6% H: 0.0% C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M

Health Technology

| -2.05% | O: -0.11% H: 0.0% C: 0.0%
results

Denali Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights
Published: 2024-02-27 (Crawled : 13:00) - globenewswire.com
SNY | News | $46.66 -2.16% -2.21% 1.7M

Health Technology

| -3.59% | O: -0.94% H: 0.0% C: 0.0%
DNLI | $15.55 -3.48% -3.6% 840K

Health Technology

| -4.62% | O: 18.06% H: 17.95% C: 17.1%
business year therapeutics financial results

Zealand Pharma Announces Financial Results for the Full Year 2023
Published: 2024-02-27 (Crawled : 06:00) - globenewswire.com
SNY | News | $46.66 -2.16% -2.21% 1.7M

Health Technology